All filters
Slidesets
Characterization of Patients Treated with Hepatitis C - is HIV a Burden? Analysis of an Individual Experience | C. Valente
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Debate: TDF vs. TAF in HBV management | Mark Nelson, MD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Debate: TDF vs. TAF in HBV management | Douglas Dieterich, MD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Case on HEV- Antonio Rivero-Juarez, PhD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
NAFLD in HIV- infected patients- Juan Macías, MD, PhD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Failure Rate of Ultrasound Surveillance of Hepatocellular Carcinoma in HIV+ Patients | Nicolás Merchante
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
CD4-T Cell and Metabolic Changes adter DAAs: a Multicenter Study | L.A. Nicolini
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Expression of Immunological Markers in Inflammatory Infiltrate Cells of Liver in Patients with HIV/HIV Coinfection | N. Matsiyeuskaya
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Hapatitis C Reinfection after Sustained Virological Response in HIV/HCV Co-Infected Patients | Fábio Videira Santos
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
The role of Fibroscan: pre and post SVR- Nicolás Merchante, MD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Roundtable Discussion: Hepatitis A in HIV: the French, Italian, and Spanish Perspective- Massimo Puoti, MD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Roundtable Discussion: Hepatitis A in HIV: the French, Italian, and Spanish Perspective- Luz Martin-Carbonero, MD, PhD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
HAV in a Tertiary Hospital: 2017 Epidemic vs 2009-2016 Period | Andrea Lombardi, MD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Exposure-Response Analysis of Lee 1810, a Lead Spectinamide Antibiotic in Mycobacterium tuberculosis Infected Mice- Santosh Wagh
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
Improved efficacy of a cofactor-independent InhA inhibitor revealed by the C3HeB/ FeJ mouse model- Gregory Robertson
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
High dose rifampicin for the treatment of TB meningitis: a dose finding study- Rob Aarnoutse, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
Ototoxicity is associated with exposure to kanamycin and capreomycin in the treatment of multidrug-resistant tuberculosis- Mohammed Aslshaer
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
A Cardiac Risk Algorithm to Predict the Probability of Drug-Induced Torsades de Pointes with Novel Anti-TB Agents- Alexander Berg, PharmD, PhD, FCP
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
Pharmacokinetics of rifampicin in African children - Evaluation of the new WHO dosing guidelines- Paolo Denti
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
Prediction of increase in time-to-positivity after higher doses of rifampicin based on pharmacokinetic-pharmacodynamic modelling- Robin Svensson
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
Influence of Bacterial Growth Rate on Dose Optimization of Linezolid for Treatment of Tuberculosis- Kristina Bigelow
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
ADA-formation and its effect on Mab PK | Maria-Jesus Garrido, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017